SlideShare a Scribd company logo
Is femoral proficiency lost
when radial access thrives?
Stanislaw Bartus
Jagiellonian University
András Komócsi
University of Pécs, Hungary
Disclosure
I have no conflict of interest to declare
Coronarography
vasular access in 2015 vs diagnosis (in comparison to 2014)
32%
68%
femoral radial
23%
77%
femoral radial
24%
76%
femoral radial
20%
80%
femoral radial
STEMI
↑8%
NSTEMI
↑7%
UA
↑10%
SCAD
↑6%
National registry of interventional
cardiology procedures
Coronarography
radial access 2009 - 2015
National registry of interventional
cardiology procedures
24%
30%
36%
47%
59%
66%
77%
0%
20%
40%
60%
80%
100%
2009 2010 2011 2012 2013 2014 2015
ACCESS SITE PRACTICE
EVOLUTION IN THE UK
Jim Nolan, TCT 2015
When I don’t want to use radial
access ….
• Patient on dialysis
• Anticoagulation (?)
• Obesity, cachexia, low body weight, female gender, Raynaud ph,
• Patient preference
• Not possible to pass through radial/brachial/subclavian aa.
• Patient in shock, no radial pulse
• CTO, LMCA, complex procedures w/severe calcification
• Impaired Procedural success and applicability
• Learning curve
Personal experience 1996-2016
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset
by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral
Access
The Campeau Radial Paradox
Azzalini L. J Am Coll Cardiol Intv 2015;8:1854–64
The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset
by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral
Access
The Campeau Radial Paradox
Azzalini L. J Am Coll Cardiol Intv 2015;8:1854–64
Influence of Arterial Access Site Selection on Outcomes in
Primary Percutaneous Coronary Intervention
Are the Results of Randomized Trials Achievable in Clinical Practice?
Mamas M, JACC CardiovascInterv. 2013; 6: 698-706
The influence of access site
selection was studied in 46,128
PPCI patients;
TFA was used in 28,091 patients
and TRA in 18,037.
This analysis of a large number of
PPCI procedures demonstrates that
utilization of TRA is independently
associated with major reductions in
mortality, MACCE, major bleeding,
and vascular complication rates.
A. Komocsi et al.:Mortality after transradial approach in ST-segment elevation myocardial infarction.
Do we see the forest for the trees? Int J Cardiol. 2013 Oct 3;168(3):3050-3
21,321 HUMIR entries
from March 1, 2013, to March 1, 2015
17,892 angiography cases
ScreeningEligibilityIncluded
3429 patients non-invasive
treatment
Exclusion 7467 patients
due to missing data
10,485 Unmatched population
9631
transradial
808
transfemoral
1278 Matched population
639
transradial
639
Transfemoral
Propensity score calculation
and matching
Propensityscore
matched
7.7%
Clinical characteristics Entire cohort Propensity matched cohorts
Transradial
(n=9631)
Transfemoral
(n=808)
P value Transradial
(n=639)
Transfemoral
(n=639)
P value
Age, years* 63.4 ± 12.3 67.3 ± 12.2 <0.001 66.9 ± 12.4 66.3 ± 12.3 0.331
Male 62.5 56.7 <0.001 57.7 57.0 0.821
Medical history
Hypertension* 76.8 77.0 0.928 73.7 76.4 0.301
Diabetes 30.0 30.3 0.875 29.0 29.4 0.902
- insulin 11.1 15.0 0.003 12.1 13.5 0.532
Hyperlipidaemia* 37.3 37.5 0.939 37.6 38.2 0.863
Smoking *
(current/past/never)
26.7/9.9/63.5 18.9/6.7/74.4 <0.001 21.0/9.2/69.8 22.2/8.3/70.4 0.447
History of heart failure 9.4 17.7 <0.001 11.7 13.6 0.355
History of myocardial
infarction
20.5 30.4 <0.001 25.2 26.3 0.701
History of stroke* 7.8 10.5 0.006 8.3 9.7 0.434
History of PCI 18.5 25.1 <0.001 22.8 21.6 0.638
History of CABG 4.1 16.6 <0.001 7.8 8.6 0.684
Peripheral artery
disease*
12.0 14.5 0.036 13.0 13.6 0.805
STEMI* 50.6 62.3 <0.001 62.1 61.0 0.730
Killip state (I, II. III, IV) 83.6/12.2/2.2/2
.1
85.4/9.9/3.0/1.
6
0.437
Heart rate* 79.9 ± 17.3 82.0 ± 19.5 0.003 81.6 ± 18.7 81.6 ± 18.7 0.974
Systolic blood pressure* 135.4 ± 24.0 127.7 ± 30.0 <0.001 130.7 ± 24.6 131.8 ± 28.0 0.467
Diastolic blood pressure 80.1 ± 16.3 76.3 ± 19.1 <0.001 78.4 ± 14.4 78.6 ± 15.7 0.796
Weight (kg) 80.2 ± 16.3 79.0 ± 16.2 0.061 79.2 ± 17.0 78.0 ± 15.8 0.284
Follow-up (days)
Cumulativesurvival PS matched cohort (n=1278)
Log rank p < 0.05Log rank p < 0.001
STEMI
(n=787)
NSTEMI
(n=491)
Log rank p < 0.05 Log rank p = 0.07
P-value Hazard Ratio (HR)
95.0% CI for HR
Lower Upper
PS matched TRPCI 0.000 0.605 0.479 0.763
cohort TRAFO 0.000 1.766 1.336 2.332
Propensity score 0.000 181.363 58.724 560.123
NSTEMI TRPCI 0.023 0.631 0.424 0.939
TRAFO 0.000 2.234 1.458 3.423
Propensity score 0.004 21.043 2.634 168.119
STEMI TRPCI 0.001 0.602 0.452 0.803
TRAFO 0.012 1.615 1.109 2.350
Propensity score 0.000 466.801 123.976 1757.629
THERE IS NO PARADOX ?
• According to large metaanalyses, of randomized and observational
studies confirm the benefit of TR approach. However observed
complication rates are influenced and related to the documented
adverse patient and procedural characteristics
• In the current era of high TR and selective TF access, the patient
caracteristics have more important impact on survival than the access
itself of that of the transfusion
• But, be carefull: in some centers it can be observed…so train your staff
in transfemoral access !!!!
Lengyel magyar jó barát,
együtt harcol, s issza borát !
Polak, Węgier, dwa bratanki, i do szabli, i do szklanki

More Related Content

What's hot

Montalescot G - AIMRADIAL 2013 - Prasugrel and radial
Montalescot G - AIMRADIAL 2013 - Prasugrel and radialMontalescot G - AIMRADIAL 2013 - Prasugrel and radial
Montalescot G - AIMRADIAL 2013 - Prasugrel and radial
International Chair on Interventional Cardiology and Transradial Approach
 
Patel TM 201111
Patel TM 201111Patel TM 201111
Jolly SS et al
Jolly SS et alJolly SS et al
Publications from the EuroCTO registry
Publications from the EuroCTO registryPublications from the EuroCTO registry
Publications from the EuroCTO registry
Euro CTO Club
 
Patel TM 201110
Patel TM 201110Patel TM 201110
Top Cardiovascular Trials in 2012
Top Cardiovascular Trials in 2012Top Cardiovascular Trials in 2012
Top Cardiovascular Trials in 2012
Leonardo Paskah S
 
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen testKoutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
International Chair on Interventional Cardiology and Transradial Approach
 
Mann T 201111
Mann T 201111Mann T 201111
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
Ikari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPIkari Y - AIMRADIAL 2014 - Radial and IABP
Nolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterNolan J - AIMRADIAL 2014 - Heparin is better
European Journal of Heart Failure's year in Cardiology
European Journal of Heart Failure's year in CardiologyEuropean Journal of Heart Failure's year in Cardiology
European Journal of Heart Failure's year in Cardiology
drucsamal
 
Clinical papers on TAVR
Clinical papers on TAVRClinical papers on TAVR
Clinical papers on TAVR
Satya Shukla
 
Mamas M - AIMRADIAL 2014 - Cardiogenic shock
Mamas M - AIMRADIAL 2014 - Cardiogenic shockMamas M - AIMRADIAL 2014 - Cardiogenic shock
CTO in North America
CTO in North AmericaCTO in North America
CTO in North America
Euro CTO Club
 
TAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapyTAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapy
LuisArturo RV
 
Gabric ID - AIMRADIAL 2013 - Radial in STEMI
Gabric ID - AIMRADIAL 2013 - Radial in STEMIGabric ID - AIMRADIAL 2013 - Radial in STEMI
Hahalis G - AIMRADIAL 2013 - Ulnar catheterization
Hahalis G - AIMRADIAL 2013 - Ulnar catheterizationHahalis G - AIMRADIAL 2013 - Ulnar catheterization
Hahalis G - AIMRADIAL 2013 - Ulnar catheterization
International Chair on Interventional Cardiology and Transradial Approach
 
The deadly statistics of heart failure.
The deadly statistics of heart failure.The deadly statistics of heart failure.
The deadly statistics of heart failure.
drucsamal
 
09 Cohen aimradial20170922 Ventricular support
09 Cohen aimradial20170922 Ventricular support09 Cohen aimradial20170922 Ventricular support

What's hot (20)

Montalescot G - AIMRADIAL 2013 - Prasugrel and radial
Montalescot G - AIMRADIAL 2013 - Prasugrel and radialMontalescot G - AIMRADIAL 2013 - Prasugrel and radial
Montalescot G - AIMRADIAL 2013 - Prasugrel and radial
 
Patel TM 201111
Patel TM 201111Patel TM 201111
Patel TM 201111
 
Jolly SS et al
Jolly SS et alJolly SS et al
Jolly SS et al
 
Publications from the EuroCTO registry
Publications from the EuroCTO registryPublications from the EuroCTO registry
Publications from the EuroCTO registry
 
Patel TM 201110
Patel TM 201110Patel TM 201110
Patel TM 201110
 
Top Cardiovascular Trials in 2012
Top Cardiovascular Trials in 2012Top Cardiovascular Trials in 2012
Top Cardiovascular Trials in 2012
 
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen testKoutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
 
Mann T 201111
Mann T 201111Mann T 201111
Mann T 201111
 
Saito S DRAGON trial
Saito S DRAGON trialSaito S DRAGON trial
Saito S DRAGON trial
 
Ikari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABPIkari Y - AIMRADIAL 2014 - Radial and IABP
Ikari Y - AIMRADIAL 2014 - Radial and IABP
 
Nolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterNolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is better
 
European Journal of Heart Failure's year in Cardiology
European Journal of Heart Failure's year in CardiologyEuropean Journal of Heart Failure's year in Cardiology
European Journal of Heart Failure's year in Cardiology
 
Clinical papers on TAVR
Clinical papers on TAVRClinical papers on TAVR
Clinical papers on TAVR
 
Mamas M - AIMRADIAL 2014 - Cardiogenic shock
Mamas M - AIMRADIAL 2014 - Cardiogenic shockMamas M - AIMRADIAL 2014 - Cardiogenic shock
Mamas M - AIMRADIAL 2014 - Cardiogenic shock
 
CTO in North America
CTO in North AmericaCTO in North America
CTO in North America
 
TAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapyTAVR SAVR evolution of a groundbreaking therapy
TAVR SAVR evolution of a groundbreaking therapy
 
Gabric ID - AIMRADIAL 2013 - Radial in STEMI
Gabric ID - AIMRADIAL 2013 - Radial in STEMIGabric ID - AIMRADIAL 2013 - Radial in STEMI
Gabric ID - AIMRADIAL 2013 - Radial in STEMI
 
Hahalis G - AIMRADIAL 2013 - Ulnar catheterization
Hahalis G - AIMRADIAL 2013 - Ulnar catheterizationHahalis G - AIMRADIAL 2013 - Ulnar catheterization
Hahalis G - AIMRADIAL 2013 - Ulnar catheterization
 
The deadly statistics of heart failure.
The deadly statistics of heart failure.The deadly statistics of heart failure.
The deadly statistics of heart failure.
 
09 Cohen aimradial20170922 Ventricular support
09 Cohen aimradial20170922 Ventricular support09 Cohen aimradial20170922 Ventricular support
09 Cohen aimradial20170922 Ventricular support
 

Viewers also liked

21 aimradial2016 thu S Alonso
21 aimradial2016 thu S Alonso21 aimradial2016 thu S Alonso
01 aimradial2016 thu IC Gilchrist
01 aimradial2016 thu IC Gilchrist01 aimradial2016 thu IC Gilchrist
16 aimradial2016 thu A Lux case
16 aimradial2016 thu A Lux case16 aimradial2016 thu A Lux case
05 aimradial2016 thu S Sindberg ACCESS-1
05 aimradial2016 thu S Sindberg ACCESS-105 aimradial2016 thu S Sindberg ACCESS-1
15 aimradial2016 thu V Alfaro
15 aimradial2016 thu V Alfaro15 aimradial2016 thu V Alfaro
17 aimradial2016 thu A Katona Case
17 aimradial2016 thu A Katona Case17 aimradial2016 thu A Katona Case
20 aimradial2016 fri SB Pancholy
20 aimradial2016 fri SB Pancholy20 aimradial2016 fri SB Pancholy
01 aimradial2016 thu2 B Speiser
01 aimradial2016 thu2 B Speiser01 aimradial2016 thu2 B Speiser
17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFR17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFR
International Chair on Interventional Cardiology and Transradial Approach
 
10 FFR Berry C aimradial2016 - FAME trials
10 FFR Berry C aimradial2016 - FAME trials10 FFR Berry C aimradial2016 - FAME trials
11 aimradial2016 fri V Dangoisse
11 aimradial2016 fri  V Dangoisse11 aimradial2016 fri  V Dangoisse
07 aimradial2016 fri2 P Montorsi
07 aimradial2016 fri2 P Montorsi07 aimradial2016 fri2 P Montorsi
06 aimradial2016 fri2 A Noor
06 aimradial2016 fri2 A Noor06 aimradial2016 fri2 A Noor
11 aimradial2016 fri2 T Kwan
11 aimradial2016 fri2 T Kwan11 aimradial2016 fri2 T Kwan
Zelizko M
Zelizko MZelizko M
Shapiro T 201110
Shapiro T 201110Shapiro T 201110
Leon MB - Current perspectives
Leon MB - Current perspectivesLeon MB - Current perspectives
Cohen MG 201305
Cohen MG 201305Cohen MG 201305
Teirstein P - Transitioning to radial
Teirstein P - Transitioning to radialTeirstein P - Transitioning to radial

Viewers also liked (20)

21 aimradial2016 thu S Alonso
21 aimradial2016 thu S Alonso21 aimradial2016 thu S Alonso
21 aimradial2016 thu S Alonso
 
01 aimradial2016 thu IC Gilchrist
01 aimradial2016 thu IC Gilchrist01 aimradial2016 thu IC Gilchrist
01 aimradial2016 thu IC Gilchrist
 
16 aimradial2016 thu A Lux case
16 aimradial2016 thu A Lux case16 aimradial2016 thu A Lux case
16 aimradial2016 thu A Lux case
 
05 aimradial2016 thu S Sindberg ACCESS-1
05 aimradial2016 thu S Sindberg ACCESS-105 aimradial2016 thu S Sindberg ACCESS-1
05 aimradial2016 thu S Sindberg ACCESS-1
 
15 aimradial2016 thu V Alfaro
15 aimradial2016 thu V Alfaro15 aimradial2016 thu V Alfaro
15 aimradial2016 thu V Alfaro
 
17 aimradial2016 thu A Katona Case
17 aimradial2016 thu A Katona Case17 aimradial2016 thu A Katona Case
17 aimradial2016 thu A Katona Case
 
20 aimradial2016 fri SB Pancholy
20 aimradial2016 fri SB Pancholy20 aimradial2016 fri SB Pancholy
20 aimradial2016 fri SB Pancholy
 
01 aimradial2016 thu2 B Speiser
01 aimradial2016 thu2 B Speiser01 aimradial2016 thu2 B Speiser
01 aimradial2016 thu2 B Speiser
 
17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFR17 FFR Bertrand OF aimradial2016 - post-pci FFR
17 FFR Bertrand OF aimradial2016 - post-pci FFR
 
10 FFR Berry C aimradial2016 - FAME trials
10 FFR Berry C aimradial2016 - FAME trials10 FFR Berry C aimradial2016 - FAME trials
10 FFR Berry C aimradial2016 - FAME trials
 
11 aimradial2016 fri V Dangoisse
11 aimradial2016 fri  V Dangoisse11 aimradial2016 fri  V Dangoisse
11 aimradial2016 fri V Dangoisse
 
07 aimradial2016 fri2 P Montorsi
07 aimradial2016 fri2 P Montorsi07 aimradial2016 fri2 P Montorsi
07 aimradial2016 fri2 P Montorsi
 
06 aimradial2016 fri2 A Noor
06 aimradial2016 fri2 A Noor06 aimradial2016 fri2 A Noor
06 aimradial2016 fri2 A Noor
 
11 aimradial2016 fri2 T Kwan
11 aimradial2016 fri2 T Kwan11 aimradial2016 fri2 T Kwan
11 aimradial2016 fri2 T Kwan
 
Zelizko M
Zelizko MZelizko M
Zelizko M
 
Shapiro T 201110
Shapiro T 201110Shapiro T 201110
Shapiro T 201110
 
Leon MB - Current perspectives
Leon MB - Current perspectivesLeon MB - Current perspectives
Leon MB - Current perspectives
 
Cohen MG 201305
Cohen MG 201305Cohen MG 201305
Cohen MG 201305
 
Teirstein P - Transitioning to radial
Teirstein P - Transitioning to radialTeirstein P - Transitioning to radial
Teirstein P - Transitioning to radial
 
Hell ratio
Hell ratioHell ratio
Hell ratio
 

Similar to 04 aimradial2016 thu S Bartus

03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device
International Chair on Interventional Cardiology and Transradial Approach
 
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
International Chair on Interventional Cardiology and Transradial Approach
 
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Euro CTO Club
 
Benamer H
Benamer HBenamer H
Valgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradialValgimigli M 2015 MATRIX trial transradial
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCIRigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
International Chair on Interventional Cardiology and Transradial Approach
 
12 Valgimigli aimradial20170921 MATRIX program
12 Valgimigli aimradial20170921 MATRIX program12 Valgimigli aimradial20170921 MATRIX program
Wivon
WivonWivon
Romagnoli E 201305
Romagnoli E 201305Romagnoli E 201305
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stentE-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
International Chair on Interventional Cardiology and Transradial Approach
 
Twilight complex study
Twilight complex studyTwilight complex study
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approachDe Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
International Chair on Interventional Cardiology and Transradial Approach
 
01 Due-Tonnessen aimradial20170922 Hemostasis device
01 Due-Tonnessen aimradial20170922 Hemostasis device01 Due-Tonnessen aimradial20170922 Hemostasis device
01 Due-Tonnessen aimradial20170922 Hemostasis device
International Chair on Interventional Cardiology and Transradial Approach
 
Cohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCICohen MG - AIMRADIAL 2013 - Complex PCI
Pancholy SB 2014
Pancholy SB 2014Pancholy SB 2014
Thromboectomy trial
Thromboectomy trialThromboectomy trial
Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507Yeh RW - Femoral vs radial: evidence - 201507
Cabg is superior to pci in heart failure patients with multivessel disease pro
Cabg is superior to pci in heart failure patients with multivessel disease proCabg is superior to pci in heart failure patients with multivessel disease pro
Cabg is superior to pci in heart failure patients with multivessel disease pro
drucsamal
 
Tct surya dharma
Tct surya dharmaTct surya dharma
Tct surya dharma
AndiPutrama1
 
Carotid Artery Stenting
Carotid Artery StentingCarotid Artery Stenting
Carotid Artery Stenting
Dr Vipul Gupta
 

Similar to 04 aimradial2016 thu S Bartus (20)

03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device03 Wainstein aimradial20170922 Compression device
03 Wainstein aimradial20170922 Compression device
 
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
Dharma S - AIMRADIAL 2014 - Nitroglycerin and radial artery occlusion
 
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
Carlo Di Mario - Recent Publications & Research in CTO: 2015-16
 
Benamer H
Benamer HBenamer H
Benamer H
 
Valgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradialValgimigli M 2015 MATRIX trial transradial
Valgimigli M 2015 MATRIX trial transradial
 
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCIRigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
Rigattieri S - AIMRADIAL 2015 - Transradial and primary PCI
 
12 Valgimigli aimradial20170921 MATRIX program
12 Valgimigli aimradial20170921 MATRIX program12 Valgimigli aimradial20170921 MATRIX program
12 Valgimigli aimradial20170921 MATRIX program
 
Wivon
WivonWivon
Wivon
 
Romagnoli E 201305
Romagnoli E 201305Romagnoli E 201305
Romagnoli E 201305
 
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stentE-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
E-poster09 Iniguez aimradial20170921 Transradial bioresorbable stent
 
Twilight complex study
Twilight complex studyTwilight complex study
Twilight complex study
 
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approachDe Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
De Andrade PB - AIMRADIAL 2015 - Angio-Seal vs radial approach
 
01 Due-Tonnessen aimradial20170922 Hemostasis device
01 Due-Tonnessen aimradial20170922 Hemostasis device01 Due-Tonnessen aimradial20170922 Hemostasis device
01 Due-Tonnessen aimradial20170922 Hemostasis device
 
Cohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCICohen MG - AIMRADIAL 2013 - Complex PCI
Cohen MG - AIMRADIAL 2013 - Complex PCI
 
Pancholy SB 2014
Pancholy SB 2014Pancholy SB 2014
Pancholy SB 2014
 
Thromboectomy trial
Thromboectomy trialThromboectomy trial
Thromboectomy trial
 
Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507Yeh RW - Femoral vs radial: evidence - 201507
Yeh RW - Femoral vs radial: evidence - 201507
 
Cabg is superior to pci in heart failure patients with multivessel disease pro
Cabg is superior to pci in heart failure patients with multivessel disease proCabg is superior to pci in heart failure patients with multivessel disease pro
Cabg is superior to pci in heart failure patients with multivessel disease pro
 
Tct surya dharma
Tct surya dharmaTct surya dharma
Tct surya dharma
 
Carotid Artery Stenting
Carotid Artery StentingCarotid Artery Stenting
Carotid Artery Stenting
 

More from International Chair on Interventional Cardiology and Transradial Approach

PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses GalazPCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo BernatPCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán RuzsaPCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim NolanPCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C GilchristPCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C GilchristPCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. BertrandPCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. FearonPCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
International Chair on Interventional Cardiology and Transradial Approach
 
PCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin BerryPCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
International Chair on Interventional Cardiology and Transradial Approach
 

More from International Chair on Interventional Cardiology and Transradial Approach (20)

PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
 
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses GalazPCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
PCI & AimRadial 2018 | A novel stent concept for South America - Ramses Galaz
 
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
PCI & AimRadial 2018 | Biomechanics of biodegradable stents: a primer for car...
 
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
PCI & AimRadial 2018 | Radial vs Femoral: Review of the Evidence in 2018 - Ia...
 
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo BernatPCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
PCI & AimRadial 2018 | Best practices in same day discharge - Ivo Bernat
 
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán RuzsaPCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
PCI & AimRadial 2018 | Even the big boss fail - Zoltán Ruzsa
 
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
PCI & AimRadial 2018 | Contemporary Transradial Access Practices: Results of ...
 
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
PCI & AimRadial 2018 | A Growing Population in the Cath Lab: Patient Identifi...
 
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
PCI & AimRadial 2018 | Treating Cardiogenic Shock with Impella with Escalatio...
 
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim NolanPCI & AimRadial 2018 | LEFT MAIN PCILessons from the BCIS registry - Jim Nolan
PCI & AimRadial 2018 | LEFT MAIN PCI Lessons from the BCIS registry - Jim Nolan
 
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by  Transradial...
PCI & AimRadial 2018 | Left Ventricular Endomyocardial Biopsy by Transradial...
 
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C GilchristPCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
PCI & AimRadial 2018 | Right Heart Access by Radial - Ian C Gilchrist
 
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C GilchristPCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
PCI & AimRadial 2018 | Radial Artery Puncture - Ian C Gilchrist
 
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. BertrandPCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
PCI & AimRadial 2018 | Post-PCI FFR: Time is coming - Olivier F. Bertrand
 
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
PCI & AimRadial 2018 | Lessons from iFR-SWEDEHEART and DEFINE-FLAIR - Hitoshi...
 
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
PCI & AimRadial 2018 | Use of physiology in ACS - Colin Berry
 
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
PCI & AimRadial 2018 | FFR using 4Fr catheters: Can Slender Technique Work He...
 
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. FearonPCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
PCI & AimRadial 2018 | FFR in Left Main Disease - William F. Fearon
 
PCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin BerryPCI & AimRadial 2018 | FFR-CT - Colin Berry
PCI & AimRadial 2018 | FFR-CT - Colin Berry
 
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
PCI & AimRadial 2018 | Image based FFR during coronary angiography - Hitoshi...
 

Recently uploaded

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 

Recently uploaded (20)

Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 

04 aimradial2016 thu S Bartus

  • 1. Is femoral proficiency lost when radial access thrives? Stanislaw Bartus Jagiellonian University András Komócsi University of Pécs, Hungary
  • 2. Disclosure I have no conflict of interest to declare
  • 3. Coronarography vasular access in 2015 vs diagnosis (in comparison to 2014) 32% 68% femoral radial 23% 77% femoral radial 24% 76% femoral radial 20% 80% femoral radial STEMI ↑8% NSTEMI ↑7% UA ↑10% SCAD ↑6% National registry of interventional cardiology procedures
  • 4. Coronarography radial access 2009 - 2015 National registry of interventional cardiology procedures 24% 30% 36% 47% 59% 66% 77% 0% 20% 40% 60% 80% 100% 2009 2010 2011 2012 2013 2014 2015
  • 5. ACCESS SITE PRACTICE EVOLUTION IN THE UK Jim Nolan, TCT 2015
  • 6. When I don’t want to use radial access …. • Patient on dialysis • Anticoagulation (?) • Obesity, cachexia, low body weight, female gender, Raynaud ph, • Patient preference • Not possible to pass through radial/brachial/subclavian aa. • Patient in shock, no radial pulse • CTO, LMCA, complex procedures w/severe calcification • Impaired Procedural success and applicability • Learning curve Personal experience 1996-2016
  • 7. The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access The Campeau Radial Paradox Azzalini L. J Am Coll Cardiol Intv 2015;8:1854–64
  • 8. The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access The Campeau Radial Paradox Azzalini L. J Am Coll Cardiol Intv 2015;8:1854–64
  • 9.
  • 10.
  • 11.
  • 12. Influence of Arterial Access Site Selection on Outcomes in Primary Percutaneous Coronary Intervention Are the Results of Randomized Trials Achievable in Clinical Practice? Mamas M, JACC CardiovascInterv. 2013; 6: 698-706 The influence of access site selection was studied in 46,128 PPCI patients; TFA was used in 28,091 patients and TRA in 18,037. This analysis of a large number of PPCI procedures demonstrates that utilization of TRA is independently associated with major reductions in mortality, MACCE, major bleeding, and vascular complication rates.
  • 13. A. Komocsi et al.:Mortality after transradial approach in ST-segment elevation myocardial infarction. Do we see the forest for the trees? Int J Cardiol. 2013 Oct 3;168(3):3050-3
  • 14. 21,321 HUMIR entries from March 1, 2013, to March 1, 2015 17,892 angiography cases ScreeningEligibilityIncluded 3429 patients non-invasive treatment Exclusion 7467 patients due to missing data 10,485 Unmatched population 9631 transradial 808 transfemoral 1278 Matched population 639 transradial 639 Transfemoral Propensity score calculation and matching Propensityscore matched 7.7%
  • 15. Clinical characteristics Entire cohort Propensity matched cohorts Transradial (n=9631) Transfemoral (n=808) P value Transradial (n=639) Transfemoral (n=639) P value Age, years* 63.4 ± 12.3 67.3 ± 12.2 <0.001 66.9 ± 12.4 66.3 ± 12.3 0.331 Male 62.5 56.7 <0.001 57.7 57.0 0.821 Medical history Hypertension* 76.8 77.0 0.928 73.7 76.4 0.301 Diabetes 30.0 30.3 0.875 29.0 29.4 0.902 - insulin 11.1 15.0 0.003 12.1 13.5 0.532 Hyperlipidaemia* 37.3 37.5 0.939 37.6 38.2 0.863 Smoking * (current/past/never) 26.7/9.9/63.5 18.9/6.7/74.4 <0.001 21.0/9.2/69.8 22.2/8.3/70.4 0.447 History of heart failure 9.4 17.7 <0.001 11.7 13.6 0.355 History of myocardial infarction 20.5 30.4 <0.001 25.2 26.3 0.701 History of stroke* 7.8 10.5 0.006 8.3 9.7 0.434 History of PCI 18.5 25.1 <0.001 22.8 21.6 0.638 History of CABG 4.1 16.6 <0.001 7.8 8.6 0.684 Peripheral artery disease* 12.0 14.5 0.036 13.0 13.6 0.805 STEMI* 50.6 62.3 <0.001 62.1 61.0 0.730 Killip state (I, II. III, IV) 83.6/12.2/2.2/2 .1 85.4/9.9/3.0/1. 6 0.437 Heart rate* 79.9 ± 17.3 82.0 ± 19.5 0.003 81.6 ± 18.7 81.6 ± 18.7 0.974 Systolic blood pressure* 135.4 ± 24.0 127.7 ± 30.0 <0.001 130.7 ± 24.6 131.8 ± 28.0 0.467 Diastolic blood pressure 80.1 ± 16.3 76.3 ± 19.1 <0.001 78.4 ± 14.4 78.6 ± 15.7 0.796 Weight (kg) 80.2 ± 16.3 79.0 ± 16.2 0.061 79.2 ± 17.0 78.0 ± 15.8 0.284
  • 16. Follow-up (days) Cumulativesurvival PS matched cohort (n=1278) Log rank p < 0.05Log rank p < 0.001 STEMI (n=787) NSTEMI (n=491) Log rank p < 0.05 Log rank p = 0.07 P-value Hazard Ratio (HR) 95.0% CI for HR Lower Upper PS matched TRPCI 0.000 0.605 0.479 0.763 cohort TRAFO 0.000 1.766 1.336 2.332 Propensity score 0.000 181.363 58.724 560.123 NSTEMI TRPCI 0.023 0.631 0.424 0.939 TRAFO 0.000 2.234 1.458 3.423 Propensity score 0.004 21.043 2.634 168.119 STEMI TRPCI 0.001 0.602 0.452 0.803 TRAFO 0.012 1.615 1.109 2.350 Propensity score 0.000 466.801 123.976 1757.629
  • 17. THERE IS NO PARADOX ? • According to large metaanalyses, of randomized and observational studies confirm the benefit of TR approach. However observed complication rates are influenced and related to the documented adverse patient and procedural characteristics • In the current era of high TR and selective TF access, the patient caracteristics have more important impact on survival than the access itself of that of the transfusion • But, be carefull: in some centers it can be observed…so train your staff in transfemoral access !!!! Lengyel magyar jó barát, együtt harcol, s issza borát ! Polak, Węgier, dwa bratanki, i do szabli, i do szklanki